Enanta Pharmaceuticals Inc (NASDAQ:ENTA)
| 58.45 BATS BZX Real-Time Price As of 1:06pm ET |  -0.21 / -0.36%Today’s Change | 40.37 Today|||52-Week Range 102.00 | -21.84% Year-to-Date |
Latest ENTA News | Press Releases
No recent news for Enanta Pharmaceuticals Inc.
Today’s Trading
| Previous close | 58.66 |
| Today’s open | 59.77 |
| Day’s range | 57.80 - 59.77 |
| Volume | 2,659 |
| Average volume (3 months) | 197,098 |
| Market cap | $1.2B |
Data as of 1:06pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | -115.92% |
| Earnings growth (this year) | -13.95% |
| Earnings growth (next 5 years) | -83.30% |
| Revenue growth (last year) | -20.74% |
| P/E ratio | NM |
| Price/Sales | 11.80 |
| Price/Book | 2.93 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| AMPHAmphastar Pharmaceut... | +0.08 | +0.32% |
| ---- | ||
| MDGLMadrigal Pharmaceuti... | +1.44 | +2.28% |
| INVAInnoviva Inc | +0.46 | +2.99% |
Data as of 1:21pm ET, 01/26/2022
Financials
| Next reporting date | February 9, 2022 |
| EPS forecast (this quarter) | -$1.11 |
| Annual revenue (last year) | $97.1M |
| Annual profit (last year) | -$79.0M |
| Net profit margin | -81.38% |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Watertown, Massachusetts |
Forecasts
